Extremely rare cause of hyperkalemia: ileostomy‒induced hyperkalemia in extremely low birth weight infants

Mehmet Mutlu1, Yakup Aslan1, Şebnem Kader1

  • 1Division of Neonatology, Karadeniz Technical University, Faculty of Medicine, Trabzon, Türkiye.

Insights

Ileostomy-induced hyperkalemia, a serious condition, was observed in two extremely low birth weight infants. Prompt resolution occurred after ileostomy closure, highlighting gastrointestinal integrity

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Clinical Pediatrics

Background:

  • Hyperkalemia is a critical electrolyte imbalance with potentially lethal cardiac consequences.
  • While documented in adults, ileostomy-associated hyperkalemia is rare in neonates.

Observation:

  • Two extremely low birth weight (ELBW) infants (850g, 840g) presented with persistent hyperkalemia during ileostomy.
  • Hyperkalemia resolved rapidly following ileostomy closure in both cases.

Findings:

  • Disruption of intestinal integrity in ELBW infants can precipitate hyperkalemia.
  • The gastrointestinal tract's integrity is crucial for managing electrolyte disorders like hyperkalemia in neonates with ileostomies.

Implications:

  • This study underscores the importance of monitoring electrolytes in ELBW infants with ileostomies.
  • Maintaining gastrointestinal integrity is vital for preventing and treating hyperkalemia in this vulnerable population.
Abstract

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
504
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
563
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
962
Renal Tubule and Collecting Duct01:24

Renal Tubule and Collecting Duct

The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
900
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Reabsorption and Secretion in the Loop of Henle01:17

Reabsorption and Secretion in the Loop of Henle

The thick ascending limb of the nephron loop has Na+–K+–2Cl− symporters in the apical membranes of its cells. These symporters simultaneously reclaim one sodium ion, one potassium ion, and two chloride ions from the tubular fluid. Sodium ions are actively transported into the interstitial fluid at the base and sides of the cell, diffusing into the vasa recta. Chloride ions move through leakage channels in the basolateral membrane into the interstitial fluid and then into the...
1.1K